Abstract

In the present work, the dicyandiamide N-doped supra-CNDs were synthesized just within 24 h. The supra-CNDs exhibited a new strong absorption band at longer wavelengths (450–900 nm) and higher photothermal conversion efficiency (55.49 % and 46.02 % irradiation at 730 nm and 808 nm, respectively). The supra-CNDs can still maintain excellent photothermal stability and reusability after three on/off cycles. The survival rate of cancer cells incubated with supra-CNDs was above 90 %, but the value was drastically reduced to 4.24 % and 7.25 % after strong photothermal ablation at 730 nm and 808 nm, respectively. The cell killing ability of the supra-CNDs was also validated by photothermal ablation experiment. The excellent photothermal performance and low toxicity make the supra-CNDs highly promising application in photothermal therapy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.